Followers | 813 |
Posts | 30684 |
Boards Moderated | 5 |
Alias Born | 03/22/2016 |
![](https://investorshub.advfn.com/uicon/558887.png?cb=1697550425)
Wednesday, March 27, 2024 11:55:24 AM
Recent NUVB News
- Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting • Business Wire • 06/01/2024 12:10:00 PM
- Nuvation Bio to Present at the Jefferies Global Healthcare Conference • Business Wire • 05/29/2024 08:05:00 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 05/24/2024 09:22:30 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/24/2024 08:40:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:28:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:20:59 PM
- Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update • Business Wire • 05/14/2024 08:05:00 PM
- Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • Business Wire • 04/24/2024 02:01:00 PM
- Nuvation Bio Completes Acquisition of AnHeart Therapeutics • Business Wire • 04/10/2024 08:01:00 PM
- Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer • Business Wire • 03/28/2024 12:00:00 PM
- Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction • Business Wire • 03/25/2024 11:00:00 AM
- Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors • Business Wire • 03/14/2024 08:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/04/2024 10:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:22:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:40:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:27:28 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 10:06:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:48:41 PM
- Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • Business Wire • 02/29/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 09:22:44 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 09:21:29 PM
- Nuvation Bio Gets New Drug Application Clearance From FDA for Solid Tumor Treatment • Dow Jones News • 01/08/2024 09:58:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:17:00 PM
- Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of Directors • Business Wire • 01/08/2024 09:10:00 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM